Auscann announces pharmaceutical packaging agreement with Aspen Pharmacare (ASX:AC8) 25 Nov, 2019 11:13 AM Highlights AusCann has appointed TGA licensed Aspen Pharmacare Australia to provide packaging services for its medicinal cannabis pharmaceutical products. Appointment of Aspen Pharmacare is ...read more
AusCann Announce June 2019 Quarterly Activities and Cashflow Reports (ASX:AC8) 31 Jul, 2019 03:42 PM AusCann strengthens strategic partnerships during June Quarter Highlights Commencement of Mr Ido Kanyon as new CEO of AusCann First commercial shipment of medical cannabis concentrate...read more
AusCann Announces New Supply Agreement with TasAlk (ASX:AC8) 01 Jul, 2019 02:42 PM Highlights New agreement with TasAlk secures the supply of high-quality cannabis resin to AusCann Resin supply to be used for future production and development of AusCann’s cannabi...read more
AusCann, Appendix 4D and Half Year Financial Report, 31 December 2018 (ASX:AC8) 28 Feb, 2019 04:26 PM TABLE OF CONTENTS - DIRECTORS’ REPORT - AUDITOR’S INDEPENDENCE DECLARATION - CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME - CONSOLIDATED STATEMENT OF...read more
AusCann Announces Experienced Global Pharmaceutical Executive Appointed as new CEO (ASX:AC8) 25 Feb, 2019 08:10 AM 25 February 2019 – The Board of leading medicinal cannabis company AusCann Group Holdings Limited (ASX:AC8) (‘AusCann’ or ‘the Company’) is pleased to announce the appoin...read more
AusCann Announces Cannabis Resin Supply Agreement Signed with Canadian MediPharm Labs (ASX:AC8) 22 Feb, 2019 02:23 PM 21 February 2019 – Leading medical cannabis company AusCann Group Holdings Limited (ASX:AC8) (‘AusCann’ or ‘the Company’) is pleased to announce it has entered into a Sup...read more
AusCann, Quarterly Activities Report and Appendix 4C Quarter ended December 2018 (ASX:AC8) 31 Jan, 2019 11:01 AM AusCann advances the development of cannabinoid hard shell capsules Highlights Agreement with PCI Pharma to manufacture AusCann’s cannabinoid hard shell capsules DayaCann and Khiron L...read more
AusCann Announces Research and Development Facility Established (ASX:AC8) 25 Jan, 2019 10:41 AM Highlights AusCann completes acquisition of R&D facility in Perth, Western Australia to further develop its cannabinoid pharmaceutical product pipeline. Site to be state of the art, fully ...read more
AusCann Announces Joint Venture Commences First Cultivation Activity with Khiron Life Sciences Corp (ASX:AC8) 22 Jan, 2019 10:55 AM 22nd January 2019 – Leading Australian medicinal cannabis company AusCann Group Holdings Limited (ASX:AC8) (AusCann or ‘the Company’) is pleased to announce its DayaCann joint ventur...read more
AusCann Provides Leadership Transition Update (ASX:AC8) 18 Dec, 2018 12:00 PM Monday, 17 December 2018 – Leading medical cannabis company AusCann Group Holdings Limited (ASX:AC8) (AusCann or ‘the Company’) wishes to provide an update on the Company’s CEO...read more
AusCann Announces PCI Pharma Appointed to Manufacture its First Medicinal Cannabis Product Line (ASX:AC8) 13 Nov, 2018 12:36 PM Highlights AusCann appoints TGA licensed PCI Pharma to manufacture and release its first medicinal cannabis product line. New proprietary solid hard shell capsules for treatment of chronic pai...read more
AusCann on Track for Launch of Validated Cannabinoid Medicines in 2019 (ASX:AC8) 30 Oct, 2018 11:43 AM Highlights Completion of successful pilot production of AusCann’s final dose form cannabinoid hard shell capsules This success enables the move of the production process into a commercia...read more
AusCann Announces Release of Cannabinoid Medical Education Resources (ASX:AC8) 02 Oct, 2018 11:03 AM Highlights AusCann releases online education courses as part of its Medical Outreach Program to support Australian health professionals make informed decisions regarding cannabinoid therapeutics. ...read more
AusCann Joint Venture Signs MoU with Columbian based Khiron Life Sciences Corp (ASX:AC8) 01 Oct, 2018 11:09 AM Highlights AusCann’s Chilean joint venture DayaCann has signed a non-binding MoU with Canadian listed medical cannabis company Khiron Life Sciences Corp. (TSXV:KHRN) AusCann and Fundacio...read more
AusCann Announces Pharmaceutical Executive Joins Board (ASX:AC8) 27 Sep, 2018 11:35 AM Thursday, 27 September 2018 – Leading medical cannabis company AusCann Group Holdings Limited (ASX:AC8) (AusCann or ‘the Company’) is pleased to advise that experienced pharmaceutica...read more